Related Experiment Video

Updated: Aug 6, 2026

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 7, 2013

Innovations in oligonucleotide drug delivery

Melanie A Lysik1, Susanna Wu-Pong

  • 1Midwestern University, College of Pharmacy-Glendale, Department of Pharmaceutical Sciences, 19555 N 59th Avenue, Glendale, Arizona 18308, USA. mlysik@Arizona.midwester.edu

Journal of Pharmaceutical Sciences
|July 29, 2003
PubMed

Insights

Oligonucleotides show therapeutic promise but face delivery challenges. This review explores innovative delivery methods to enhance oligonucleotide uptake, efficacy, and cost-effectiveness for treating diseases like cancer and HIV.

Area of Science:

  • Biotechnology
  • Drug Delivery
  • Molecular Therapeutics

Background:

  • Oligonucleotides (ONs) are emerging therapeutic agents for diseases including cancer and HIV.
  • Poor cellular uptake and unclear uptake mechanisms limit ON efficacy.
  • Existing delivery methods often bypass endocytosis to improve targeting and stability.

Purpose of the Study:

  • To review traditional and novel delivery mechanisms for oligonucleotides.
  • To highlight strategies for enhancing cellular delivery and therapeutic efficacy.
  • To discuss improvements in cost-effectiveness for oligonucleotide-based therapies.

Main Methods:

  • Review of scientific literature on oligonucleotide delivery systems.
  • Analysis of various traditional and novel delivery approaches.
  • Examination of methods to overcome cellular barriers to ON uptake.

Main Results:

  • Delivery vehicles can significantly improve cellular uptake of oligonucleotides.
  • Targeted delivery systems enhance specificity and drug stability.
  • Novel strategies offer potential for improved therapeutic outcomes and cost-efficiency.

Conclusions:

  • Effective delivery is crucial for realizing the therapeutic potential of oligonucleotides.
  • Advancements in delivery mechanisms are key to overcoming current limitations.
  • Optimized delivery strategies will broaden the application of ONs in medicine.

More Related Videos

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Related Concept Videos

Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...